DUBLIN, May 31, 2018 /PRNewswire/ --
The "Molecular Diagnostics Market by Application, Technology, End User, Product & Service - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global molecular diagnostics market is projected to reach USD 11.54 Billion by 2023 from USD 7.71 Billion in 2018, at CAGR of 8.4%.
Molecular diagnostics is a technique used to identify and analyze nucleic acids or proteins at a molecular level. This technique assesses the genetic makeup of an individual to identify predisposition to a particular disease or condition and diagnose it. Growth in this market is largely driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. On the other hand, the presence of complex regulatory frameworks for the approval of molecular diagnostic tests is one of the major factors restraining the growth of this market.
On the basis of product and service, the market is broadly segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018 and is projected to register the highest CAGR during the forecast period. The availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents are expected to drive the market for molecular diagnostic reagents and kits in the coming years.
Based on application, the market is segmented into infectious diseases, oncology, genetic tests, and other applications. The infectious diseases segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the development of advanced assays for different diseases and conditions, significant increase in the prevalence of infectious diseases, and rising awareness about the effective use of molecular diagnostic technologies or products to control the occurrence and spread of infectious diseases.
Based on technology, the molecular diagnostics market is segmented into PCR, INAAT, DNA sequencing & NGS, in situ hybridization, DNA microarrays, and other technologies. In 2018, the PCR segment is expected to account for the largest share of the global molecular diagnostics market. The large share of this segment can be attributed to the growing use of PCR in proteomics and genomics, automation of PCR instruments, and the emergence of advanced technologies like qRT-PCR.
On the basis of end user, the market is segmented into hospitals and academic laboratories, reference laboratories, and other end users. In 2018, the hospitals and academic laboratories segment is expected to account for the largest share of the global molecular diagnostics market. The large share of this segment can primarily be attributed to the large number of diagnostic tests conducted in hospitals.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Molecular Diagnostics: Market Overview
4.2 Molecular Diagnostics Market, By Technology and Region, 2018
4.3 Molecular Diagnostics Market, By Product and Service, 2018 vs 2023 (USD Billion)
4.4 Molecular Diagnostics Market, By End User
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Infectious Diseases and Various Types of Cancers
5.2.1.2 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
5.2.1.3 Growth in the Biomarker Identification Market and Advancements in Molecular Techniques
5.2.2 Restraints
5.2.2.1 Complex Regulatory Frameworks Delaying the Approval of New Molecular Diagnostic Tests
5.2.3 Opportunities
5.2.3.1 Advances in Genomics and Proteomics
5.2.3.2 Growth Opportunities in Emerging Markets
5.2.4 Challenges
5.2.4.1 Dearth of Trained Professionals Limiting the Appropriate Use of New Molecular Diagnostic Technologies
6 Molecular Diagnostics Market, By Product & Service
6.1 Introduction
6.2 Reagents & Kits
6.3 Instruments
6.4 Services & Software
7 Molecular Diagnostics Market, By Technology
7.1 Introduction
7.2 Polymerase Chain Reaction (PCR)
7.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4 DNA Sequencing & Next-Generation Sequencing (NGS)
7.5 in Situ Hybridization
7.6 DNA Microarray
7.7 Other Technologies
8 Molecular Diagnostics Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 Hepatitis
8.2.2 HIV
8.2.3 CT/NG
8.2.4 HAIS
8.2.5 HPV
8.2.6 Tuberculosis
8.2.7 Influenza
8.2.8 Other Infectious Diseases
8.3 Oncology
8.3.1 Breast Cancer
8.3.2 Colorectal Cancer
8.3.3 Lung Cancer
8.3.4 Prostate Cancer
8.3.5 Other Cancers
8.4 Genetic Tests
8.5 Other Applications
9 Molecular Diagnostics Market, By End User
9.1 Introduction
9.2 Hospital & Academic Laboratories
9.3 Reference Laboratories
9.4 Other End Users
10 Molecular Diagnostics Market, By Region
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.3 Molecular Diagnostics Market Competitive Share Analysis, By Application
11.3.1 Market Share Analysis for Infectious Disease Applications
11.3.2 Molecular Diagnostics Market Share Analysis, By Technology
11.3.2.1 Polymerase Chain Reaction (PCR)
11.3.2.2 DNA Sequencing and NGS
11.3.2.3 in Situ Hybridization (ISH)
11.4 Competitive Situation and Trends
11.4.1 New Product Launches and Approvals, 2016-2018
11.4.2 Agreements, Partnerships, and Collaborations, 2016-2018
11.4.3 Acquisitions and Mergers
11.4.4 Expansions
12 Company Profiles
12.1 Abbott Laboratories
12.2 Agilent Technologies
12.3 Becton, Dickinson and Company
12.4 Biomrieux Sa
12.5 Danaher Corporation
12.6 Diasorin
12.7 Grifols
12.8 Hologic
12.9 Illumina
12.10 Qiagen
12.11 Roche Diagnostics
12.12 Siemens AG
12.13 Thermo Fisher Scientific
For more information about this report visit
https://www.researchandmarkets.com/research/lrn7dm/global_molecular?w=5
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article